Patents Assigned to COMPOUND SOLUTIONS, INC.
  • Publication number: 20230263746
    Abstract: Compositions and methods are provided to increase the healthspan of a subject. Most typically, contemplated compositions are formulated for oral administration and comprise a synergistic combination of a first and a second polyamine (e.g., spermine and spermidine).
    Type: Application
    Filed: February 23, 2023
    Publication date: August 24, 2023
    Applicant: Compound Solutions Inc.
    Inventor: Matthew Titlow
  • Publication number: 20230219881
    Abstract: A simplified synthetic process for production of spermine and spermidine are presented that can provide spermine and spermidine in free base or salt form. Advantageously, the synthetic procedure is safe, simple, and environmentally friendly, while at the same time also being cost-effective.
    Type: Application
    Filed: December 20, 2022
    Publication date: July 13, 2023
    Applicants: Compound Solutions Inc., Shaoxing King-Year Biochemical Co., Ltd.
    Inventors: Matthew Titlow, Xinglong Gu
  • Patent number: 11141442
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 12, 2021
    Assignee: Compound Solutions, Inc.
    Inventor: Matthew Titlow
  • Patent number: 11045509
    Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: June 29, 2021
    Assignee: COMPOUND SOLUTIONS, INC.
    Inventor: Matthew Titlow